#United States #Bethesda #Lung Cancer #LUNGevity Foundation #London Marathon

LUNGevity Foundation Joins the 2027 Double TCS London Marathon

In a significant development for the lung cancer community, the LUNGevity Foundation has announced its participation as an official charity for the upcoming 2027 Double TCS London Marathon. This marathon, renowned as one of the largest in the world, presents a unique opportunity for runners to support lung cancer research and patient advocacy on a global stage.

Expanding Support for Lung Cancer

This announcement marks a milestone for Team LUNGevity as it becomes a charity partner in seven out of the eight Abbott World Marathon Majors, positioning it at the forefront of fundraising initiatives aimed at enhancing the lives of individuals affected by lung cancer. The selection of LUNGevity is a recognition of its continuous efforts to improve lung cancer outcomes through research, education, and advocacy.

Over the past fiscal year, Team LUNGevity has demonstrated remarkable success, raising nearly $750,000 dedicated to lung cancer research and support programs. Katie Ginda, the organization's Director of Development, expressed enthusiasm about the marathon partnership. She emphasized that every runner joining their team would help fast-track research, support patients and their families, and raise awareness about lung cancer, which can affect anyone.

A Unique Marathon Format

The 2027 Double TCS London Marathon is set to take place over two days, making it the world's largest marathon with an anticipated 100,000 runners. This innovative approach is expected to create an unprecedented fundraising moment for UK sports, allowing Team LUNGevity to play a pivotal role in this significant occasion.

As a charity partner, Team LUNGevity will provide guaranteed race entries to runners who commit to fundraising for its mission. Participants can expect personalized coaching, exclusive merchandise, and access to a community united by the goal of eradicating lung cancer.

Why This Matters

The mission of LUNGevity is deeply impactful, considering the alarming statistics associated with lung cancer. In the United States, approximately 1 in 19 individuals will be diagnosed with this disease during their lifetime, with more than 229,410 new cases expected this year alone. Notably, nearly 65% of those diagnosed have either no history of tobacco use or only past exposure.

Despite being the leading cause of cancer-related deaths, awareness and funding for lung cancer research lag behind other cancers. By participating in events like the London Marathon, LUNGevity aims to change the narrative and improve access to necessary screenings, treatments, and patient support.

Join the Movement

Applications to join Team LUNGevity for the 2027 London Marathon are currently open, with a deadline set for August 16. Interested individuals can apply and find additional information at Team LUNGevity's website. Whether you're a seasoned marathon runner or a newcomer, every effort made to fundraise can contribute significantly to the fight against lung cancer.

By turning passion into purpose through endurance events, Team LUNGevity exemplifies how athletic endeavors can support groundbreaking research. Together, they strive to ensure that advancements in lung cancer treatments reach those in need, creating a future where lung cancer is no longer a death sentence.

About LUNGevity Foundation

LUNGevity Foundation stands as the largest nonprofit organization devoted to lung cancer research funding in the United States. Its multi-faceted approach encompasses research, advocacy, and patient support, aiming to connect these critical elements for comprehensive progress. The foundation advocates for policies that promote better access to care and resources, ensuring that every patient has the opportunity to benefit from scientific advancements.

For those interested in learning more about lung cancer or supporting the cause, further information can be found on their official website: www.LUNGevity.org. Every contribution brings awareness to the urgency of lung cancer research, fostering hope for countless lives affected by this disease.